Session Details

[2-O]Oral Presentation

Tue. Mar 17, 2026 10:10 AM - 11:25 AM JST
Tue. Mar 17, 2026 1:10 AM - 2:25 AM UTC
Room 10(B102)
Chair:Tsugunobu Andoh(Kinjo Gakuin University), Takuya Yamaguchi(Nihon University College of Bioresource Sciences)

[2-O-11]Ghrelin signaling in the brain ameliorates the pathogenesis of myocardial infarction in mice

*Koichi Yoshida1, Daiki Masukawa1, Tomohiro Shibata1, Takeshi Tokudome1 (1. Yokohama City University School of Medicine)
Comment()

[2-O-12]Establishment of a brain tumor PDX intracerebral transplant model

*Shinichiro Tsunesumi1, Misato Moriguchi1, Zhe Sun1, Shigenori Enoki1, Kosuke Morizumi1, Shigehiro Yagishita2, Akinobu Hamada2 (1. Mediford Corporation, Drug Discovery Innovation Center, Research Unit I, 2. National Cancer Center Research Institute)
Comment()

[2-O-13]Development of Monoclonal Antibodies Targeting Glypican-1 via Cell-Based Immunization and Screening method

*Haruto Yamamoto1, Hiroyuki Suzuki1, Tomohiro Tanaka1, Mika K. Kaneko1, Yukinari Kato1 (1. Tohoku Univ.)
Comment()

[2-O-14]TRPM2 modulates reactive oxygen species–induced cytokine production via Ca2+– and NF-κB–dependent pathways in CD11b+ but not in CD68+ Kupffer cells

*Masataka Mizuno1, Takuya Yamaguchi1, Jun Yamazaki1 (1. Lab. Vet. Pharmacol., Dept. Vet. Med., Coll. of Biores. Sci., Nihon Univ.)
Comment()

[2-O-15]Involvement of tachykinin NK1 receptors in mechanical allodynia and cutaneous mast cell migration in oxaliplatin-treated mice.

*Tsugunobu Andoh1, Ayumi Kawai2 (1. Kinjo Gakuin Univ., 2. Univ. Toyama)
Comment()